ILMNILLUMINA, INC.
Laboratory Analytical Instruments
- Revenue
- $4.3B
- 0.7% YoY
- Operating margin
- 18.6%
- 198% YoY
- EBITDA
- $1.1B
- 325% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- 0.1×
- $159M net debt
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear127% of net incomeCash flow under 80% of net income
- Dilutive SBCClear6% of revenueOver 10% of revenue
- Payouts exceed cash flowClear69% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear19% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $3.2B | $4.5B | $4.5B | $4.4B | $4.3B | 0.7% |
| Operating income | $580M | −$123M | −$1.1B | −$833M | $807M | 197% |
| Net income | $656M | $762M | −$4.4B | −$1.2B | $850M | 170% |
| Operating cash flow | $1.1B | $545M | $478M | $837M | $1.1B | 29% |
| Capex | $189M | $208M | $195M | $128M | $148M | 16% |
| Stock-based comp | $194M | $754M | $380M | $370M | $275M | 26% |
| Buybacks | $736M | $0 | $0 | $116M | $742M | 540% |
Deal filings
None.
13D filers
None on file.
Insider trading
No open-market trades in the last 12 months.
Pay vs performance
| Year | CEO total comp | Comp actually paid | TSR (indexed) | Peer TSR |
|---|---|---|---|---|
| FY2025 | — | — | 36 | 122 |
| FY2024 | — | — | 37 | 92 |
| FY2023 | — | — | 55 | 89 |
| FY2022 | — | — | 103 | 99 |